Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1959 1
1962 1
1963 3
1964 1
1965 7
1966 2
1967 4
1968 1
1969 1
1970 2
1971 2
1972 1
1973 3
1974 3
1975 2
1976 2
1977 1
1978 5
1979 3
1980 3
1981 6
1982 3
1983 9
1984 3
1985 7
1986 5
1987 1
1988 2
1989 4
1990 8
1991 7
1992 7
1993 6
1994 3
1995 5
1996 4
1997 8
1998 4
1999 5
2000 2
2001 7
2002 8
2003 10
2004 16
2005 11
2006 11
2007 27
2008 26
2009 31
2010 27
2011 17
2012 11
2013 20
2014 26
2015 32
2016 26
2017 21
2018 25
2019 25
2020 41
2021 39
2022 23
Text availability
Article attribute
Article type
Publication date

Search Results

580 results
Results by year
Filters applied: . Clear all
Page 1
Glucagon stimulates gluconeogenesis by INSP3R1-mediated hepatic lipolysis.
Perry RJ, Zhang D, Guerra MT, Brill AL, Goedeke L, Nasiri AR, Rabin-Court A, Wang Y, Peng L, Dufour S, Zhang Y, Zhang XM, Butrico GM, Toussaint K, Nozaki Y, Cline GW, Petersen KF, Nathanson MH, Ehrlich BE, Shulman GI. Perry RJ, et al. Among authors: nozaki y. Nature. 2020 Mar;579(7798):279-283. doi: 10.1038/s41586-020-2074-6. Epub 2020 Mar 4. Nature. 2020. PMID: 32132708 Free PMC article.
Antidiabetic Therapy in the Treatment of Nonalcoholic Steatohepatitis.
Sumida Y, Yoneda M, Tokushige K, Kawanaka M, Fujii H, Yoneda M, Imajo K, Takahashi H, Eguchi Y, Ono M, Nozaki Y, Hyogo H, Koseki M, Yoshida Y, Kawaguchi T, Kamada Y, Okanoue T, Nakajima A, Jsg-Nafld JSGON. Sumida Y, et al. Among authors: nozaki y. Int J Mol Sci. 2020 Mar 11;21(6):1907. doi: 10.3390/ijms21061907. Int J Mol Sci. 2020. PMID: 32168769 Free PMC article. Review.
Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease in mice.
Tanaka S, Hikita H, Tatsumi T, Sakamori R, Nozaki Y, Sakane S, Shiode Y, Nakabori T, Saito Y, Hiramatsu N, Tabata K, Kawabata T, Hamasaki M, Eguchi H, Nagano H, Yoshimori T, Takehara T. Tanaka S, et al. Among authors: nozaki y. Hepatology. 2016 Dec;64(6):1994-2014. doi: 10.1002/hep.28820. Epub 2016 Oct 21. Hepatology. 2016. PMID: 27637015
Retraction notice to "Cerebral ischemia-induced elevation of hepatic inflammatory factors accompanied by glucose intolerance suppresses hypothalamic orexin-A-mediated vagus nerve activation" [Brain Res. 1661 (2017) 100-110].
Harada S, Nozaki Y, Matsuura W, Yamazaki Y, Tokuyama S. Harada S, et al. Among authors: nozaki y. Brain Res. 2021 May 1;1758:147364. doi: 10.1016/j.brainres.2021.147364. Epub 2021 Feb 17. Brain Res. 2021. PMID: 33610263 No abstract available.
Extrinsic emotion regulation.
Nozaki Y, Mikolajczak M. Nozaki Y, et al. Emotion. 2020 Feb;20(1):10-15. doi: 10.1037/emo0000636. Emotion. 2020. PMID: 31961171 Review.
Interleukin-18 in Inflammatory Kidney Disease.
Hirooka Y, Nozaki Y. Hirooka Y, et al. Among authors: nozaki y. Front Med (Lausanne). 2021 Mar 1;8:639103. doi: 10.3389/fmed.2021.639103. eCollection 2021. Front Med (Lausanne). 2021. PMID: 33732720 Free PMC article. Review.
Comparison of atezolizumab plus bevacizumab and lenvatinib in terms of efficacy and safety as primary systemic chemotherapy for hepatocellular carcinoma.
Maesaka K, Sakamori R, Yamada R, Doi A, Tahata Y, Miyazaki M, Ohkawa K, Mita E, Iio S, Nozaki Y, Yakushijin T, Imai Y, Kodama T, Hikita H, Tatsumi T, Takehara T. Maesaka K, et al. Among authors: nozaki y. Hepatol Res. 2022 Jul;52(7):630-640. doi: 10.1111/hepr.13771. Epub 2022 Apr 25. Hepatol Res. 2022. PMID: 35417606
580 results